Vertex Stands Ready To Launch First Drug In Its Pain Franchise

NaV Channel Research Has Been A Long Journey

 
• By Mandy Jackson
  
Vertex's suzetrigine launch is on track for early 2025, pending US FDA approval (Shutterstock)

More from Strategy

More from Scrip